Evidence map›Paper›PMID 36289887›Full record

ArticleBiomedicines2022

X-ray Microtomography to Assess Determinants of In Vivo N-Butyl Cyanoacrylate Glubran

Kévin Guillen, Pierre-Olivier Comby, Anne-Virginie Salsac, Nicolas Falvo, Marc Lenfant, Alexandra Oudot, Hugo Sikner, Anne Dencausse, Emilie Laveissiere, Serge Ludwig Aho-Glele and 1 more

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Kévin GuillenDepartment of Vascular and Interventional Radiology, Image-Guided Therapy Center, François-Mitterrand University Hospital, 14 Rue Paul Gaffarel, BP 77908, 21079 Dijon, France.ORCID 0000-0003-1038-2121
Pierre-Olivier CombyImaging and Artificial Vision (ImViA) Laboratory-EA 7535, Bourgogne/Franche-Comté University, 9 Avenue Alain Savary, BP 47870, 21078 Dijon, France.ORCID 0000-0002-6651-2784
Anne-Virginie SalsacBiomechanics and Bioengineering Laboratory, UMR CNRS 7338, Université de Technologie de Compiègne, 60203 Compiègne, France.ORCID 0000-0003-4677-8793
Nicolas FalvoDepartment of Vascular and Interventional Radiology, Image-Guided Therapy Center, François-Mitterrand University Hospital, 14 Rue Paul Gaffarel, BP 77908, 21079 Dijon, France.
Marc LenfantImaging and Artificial Vision (ImViA) Laboratory-EA 7535, Bourgogne/Franche-Comté University, 9 Avenue Alain Savary, BP 47870, 21078 Dijon, France.
Alexandra OudotDepartment of Nuclear Medicine, Plateforme d'Imagerie et de Radiothérapie Préclinique, Georges-François Leclerc Center, 1 Rue Professeur Marion, BP 77980, CEDEX, 21079 Dijon, France.ORCID 0000-0002-1267-0293
Hugo SiknerDepartment of Nuclear Medicine, Plateforme d'Imagerie et de Radiothérapie Préclinique, Georges-François Leclerc Center, 1 Rue Professeur Marion, BP 77980, CEDEX, 21079 Dijon, France.
Anne DencausseR&D, Guerbet Research, CEDEX, 95943 Roissy Charles-de-Gaulle, France.ORCID 0000-0003-4665-0837
Emilie LaveissiereR&D, Guerbet Research, CEDEX, 95943 Roissy Charles-de-Gaulle, France.
Serge Ludwig Aho-GleleDepartment of Epidemiology, Statistics and Clinical Research, François-Mitterrand University Hospital, 14 Rue Paul Gaffarel, BP 77908, 21079 Dijon, France.ORCID 0000-0001-7590-8644
Romaric LoffroyDepartment of Vascular and Interventional Radiology, Image-Guided Therapy Center, François-Mitterrand University Hospital, 14 Rue Paul Gaffarel, BP 77908, 21079 Dijon, France.ORCID 0000-0002-3107-5967
Imaging, Brain, and Neuropsychiatry · FRCentre Georges François Leclerc · FRGuerbet (France) · FRMaison des Sciences sociales et des Humanités de Dijon · FRUniversité de Technologie de Compiègne · FR

Funding

Guerbet (France) APAFIS number: #25592 committee 106
6 · The paper itself

Abstract

Although introduced decades ago, few cyanoacrylate glues have been approved for endovascular use, despite evidence of their usefulness, notably for complex procedures suchas hemostatic embolization. Indications include massive bleeding requiring emergent hemostasis and prevention of severe bleeding during scheduled surgery to remove a hypervascular tumor. Adding radiopaque Lipiodol Ultra Fluid

Indexed as

3D imagingcyanoacrylatein vivolipiodolX-ray microtomography

Identifiers

PMID36289887
PMCPMC9599502
OpenAlexW4306840220

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.